| 000 | 01141 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517100651.0 | ||
| 264 | 0 | _c20180117 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1538-6899 | ||
| 024 | 7 |
_a10.1212/CON.0000000000000327 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, Aaron E | |
| 245 | 0 | 0 |
_aSwitching or Discontinuing Disease-Modifying Therapies for Multiple Sclerosis. _h[electronic resource] |
| 260 |
_bContinuum (Minneapolis, Minn.) _c06 2016 |
||
| 300 |
_a851-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Substitution _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdiagnostic imaging |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications _xdiagnostic imaging |
| 773 | 0 |
_tContinuum (Minneapolis, Minn.) _gvol. 22 _gno. 3 _gp. 851-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/CON.0000000000000327 _zAvailable from publisher's website |
| 999 |
_c26090562 _d26090562 |
||